
    
      Diabetic women with clinical symptoms attributed to diabetic gastroparesis and documentation
      of delayed gastric emptying who meet the protocol-specified entry criteria will be randomized
      to Metoclopramide Nasal Spray 10 mg or placebo administered as a single intranasal spray four
      (4) times daily; 30 minutes before meals and at bedtime for a total of four (4) weeks.
    
  